CSTL
$50.98
Castle Biosciences
($.86)
(1.66%)
CSTL
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.06)
Revenue:  $15.31 Mil
Monday
Nov 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CSTL reports earnings?
Beat
Meet
Miss

Where is CSTL's stock price going from here?
Up
Flat
Down
Stock chart of CSTL
Analysts
Summary of analysts' recommendations for CSTL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.